Phase I Trial of pH Resections of GBM at VA
Part of paid clinical trials in West Los Angeles, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT07218367
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- pH MRI based resection of GBM — PROCEDUREThis will require a chemical exchange saturation transfer MRI followed by surgical resection based on this MRI.
Study Details
Glioblastoma is an infiltrating tumor that is difficult to visualize in surgery and on standard images. A special pH (acid-base) related magnetic resonance imaging (MRI) has been developed to better see infiltrating tumor. In this safety study, the investigators will carry out increased levels of pH based resections of infiltrating tumor to assess the tolerability in VA populations.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Jul 1, 2031
- Completion
- Jul 1, 2031
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: pH ResectionsThis is a single arm study so all patients will receive the intervention
Primary Outcome Measure
Resection related adverse events [ Time Frame: 1 month ]
Central Contacts
- Kunal S Patel(310) 478-3711
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Greater Los Angeles Healthcare System, West Los Angeles, CA | West Los Angeles | California | 90073-1003 | Kunal S Patel (PRINCIPAL_INVESTIGATOR) |
Find similar trials in West Los Angeles, CA
By condition
By specialty
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2/PHASE3 · Recruiting · Global Coalition for Adaptive Research · Birmingham, Alabama
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama
- A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesPHASE1 · Recruiting · RasCal Therapeutics, Inc. · Los Angeles, California